亚临床糖尿病视网膜神经病变的早期识别:视乳头周围视网膜神经纤维层双折射降低
本研究采用偏振敏感光学相干断层扫描(PS-OCT)观察无糖尿病视网膜病变(DR)临床体征或轻中度DR的糖尿病眼视乳头周围视网膜神经纤维层(RNFL)双折射。结果显示亚临床糖尿病眼及轻中度DR眼RNFL平均总双折射较健康对照显著降低,且该变化出现在临床微血管病变或黄斑区神经节细胞复合体(GCC)改变之前。
要点
- 亚临床糖尿病眼RNFL双折射较健康对照显著降低(0.131°±0.014°/µm vs 0.143°±0.014°/µm,P=0.0033)。
- 轻中度DR眼RNFL双折射同样显著降低(0.125°±0.018°/µm,P<0.0001)。
- 糖尿病眼下方RNFL双折射显著低于上方(P<0.0001),健康对照无此差异。
核心结论
- PS-OCT测得的视乳头周围RNFL双折射降低可在临床微血管病变或GCC改变出现前提示糖尿病眼的早期神经视网膜改变。
研究设计与样本
- 观察性先导研究,纳入70只糖尿病眼(43例患者,平均年龄50.86±15.71岁)和34只健康对照眼(34例,平均年龄53.21±13.88岁)。
- 采用谱域偏振敏感OCT以视神经乳头为中心行环形扫描,通过线性拟合计算RNFL双折射,并用谱域OCT评估RNFL厚度和黄斑GCC。
主要发现
- 70只糖尿病眼中36只无DR体征、17只轻度非增殖性DR、17只中度非增殖性DR且无糖尿病黄斑水肿。
- 与健康对照(0.143°±0.014°/µm)相比,亚临床糖尿病眼RNFL平均总双折射显著降低(0.131°±0.014°/µm,P=0.0033)。
- 轻中度DR眼RNFL平均总双折射也显著降低(0.125°±0.018°/µm,P<0.0001),糖尿病患者组间差异有边缘统计学意义(P=0.0049)。
- 糖尿病眼下方RNFL平均双折射显著低于上方(P<0.0001),健康对照组未检测到该差异。
临床怎么用
- PS-OCT测量的RNFL双折射可能作为糖尿病视网膜神经病变的早期生物标志物,用于在临床微血管病变出现前识别亚临床神经视网膜改变。
- 解读RNFL双折射时需注意象限差异,糖尿病眼下方RNFL双折射降低更显著。
局限性
- 本研究为观察性先导研究,样本量有限,结论需更大规模研究验证。
- 原文未报告纵向随访数据,双折射降低与后续临床DR进展的关系尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To study birefringence of the peripapillary retinal nerve fiber layer (RNFL) of diabetic eyes with no clinical signs of diabetic retinopathy (DR) or mild to moderate DR stages using spectral-domain polarization-sensitive (PS) optical coherence tomography (OCT). METHODS: In this observational pilot study, circular PS-OCT scans centered on the optic nerve head were recorded in prospectively recruited diabetic and age-matched healthy eyes. From averaged circumpapillary intensity and retardation tomograms plots of RNFL birefringence were obtained by a linear fit of retardation versus depth within the RNFL tissue for each A-scan position and mean birefringence values for RNFL calculated. Spectral-domain OCT imaging (Heidelberg Engineering) was performed to assess peripapillary RNFL thickness and macular ganglion cell complex (GCC). RESULTS: Out of 70 eyes of 43 diabetic patients (mean ± SD age: 50.86 ± 15.71) 36 showed no signs of DR, 17 mild and 17 moderate nonproliferative DR with no diabetic macular edema. Thirty-four eyes of 34 healthy subjects (53.21 ± 13.88 years) served as controls. Compared with healthy controls (0.143° ± 0.014°/µm) mean total birefringence of peripapillary RNFL was significantly reduced in subclinical diabetic eyes (0.131° ± 0.014°/µm; P = 0.0033), as well as in mild to moderate DR stages (0.125° ± 0.018°/µm, P < 0.0001) with borderline statistically significant differences between diabetic patients (P = 0.0049). Mean birefringence values were significantly lower in inferior compared with superior RNFL sectors (P < 0.0001) of diabetic eyes with no such difference detected in the healthy control group. CONCLUSIONS: We identified evidence of early neuroretinal alteration in diabetic eyes through reduced peripapillary RNFL birefringence assessed by PS-OCT occurring before appearance of clinical microvascular lesions or GCC alterations.
引用
- Pollreisz A, Desissaire S, Sedova A, et al. Early Identification of Retinal Neuropathy in Subclinical Diabetic Eyes by Reduced Birefringence of the Peripapillary Retinal Nerve Fiber Layer. Invest Ophthalmol Vis Sci. 2021. PMID: 33871570. doi:10.1167/iovs.62.4.24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。